ORIC Pharmaceuticals will advance its prostate cancer drug to Phase III trials after it showed survival benefit in a Phase Ib study. The Himalayas-1 trial will evaluate rinzimetos ...
AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for HPP, a rare metabolic bone disorder.
The UK is currently facing a meningitis outbreak, especially in the younger population. As of 24 March, 20 laboratory cases were confirmed.
LabConnect has introduced the smartphone-based SampleGISTICS 2.0 application to digitise clinical trial sample capture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results